Subtype

Small Cell Neuroendocrine Carcinoma

396 active trials6 approved drugs7 evidence items

NCIt: C3915
MeSH: D018288

Clinical trials

Registered studies

1,165 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 396
Recruiting: 209
Ph III recruiting: 27
Growth YoY: +1%
Industry share: 42%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (167)

No study matches these filters